pamidronate has been researched along with Uveitis in 6 studies
Uveitis: Inflammation of part or all of the uvea, the middle (vascular) tunic of the eye, and commonly involving the other tunics (sclera and cornea, and the retina). (Dorland, 27th ed)
Excerpt | Relevance | Reference |
---|---|---|
"Ophthalmologic adverse effects of bisphosphonate therapy are infrequent and of unclear pathogenesis." | 6.41 | Uveitis, an under-recognized adverse effect of pamidronate. Case report and literature review. ( Acquaviva, PC; Bernard, P; Dahan, L; Daumen-Legré, V; Lafforgue, P; Pham, T; Rey, J, 2000) |
"Ophthalmologic adverse effects of bisphosphonate therapy are infrequent and of unclear pathogenesis." | 2.41 | Uveitis, an under-recognized adverse effect of pamidronate. Case report and literature review. ( Acquaviva, PC; Bernard, P; Dahan, L; Daumen-Legré, V; Lafforgue, P; Pham, T; Rey, J, 2000) |
"Uveitis and scleritis are the most serious ocular side effects of bisphosphonate therapy." | 1.35 | Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort. ( French, DD; Margo, CE, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
French, DD | 1 |
Margo, CE | 1 |
Fraunfelder, FW | 1 |
Winthrop, K | 1 |
Suhler, E | 1 |
Choi, D | 1 |
Fraunfelder, FT | 1 |
Alegre de Miquel, C | 1 |
Moreno-Ruzafa, E | 1 |
González-Fernández, MJ | 1 |
De, S | 1 |
Meyer, P | 1 |
Crisp, AJ | 1 |
Ghose, K | 1 |
Waterworth, R | 1 |
Trolove, P | 1 |
Highton, J | 1 |
Rey, J | 1 |
Daumen-Legré, V | 1 |
Pham, T | 1 |
Bernard, P | 1 |
Dahan, L | 1 |
Acquaviva, PC | 1 |
Lafforgue, P | 1 |
1 review available for pamidronate and Uveitis
Article | Year |
---|---|
Uveitis, an under-recognized adverse effect of pamidronate. Case report and literature review.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Dexamethasone; Diclofenac; Diphos | 2000 |
5 other studies available for pamidronate and Uveitis
Article | Year |
---|---|
Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort.
Topics: Administration, Oral; Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Databa | 2008 |
Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort.
Topics: Administration, Oral; Alendronate; Bone Density Conservation Agents; Databases, Factual; Diphosphona | 2009 |
[Pamidronate and uveitis].
Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Pamidronate; Uveitis | 2005 |
Pamidronate and uveitis.
Topics: Diphosphonates; Female; Humans; Middle Aged; Osteitis Deformans; Pamidronate; Streptococcus pneumoni | 1995 |
Uveitis associated with pamidronate.
Topics: Diphosphonates; Humans; Male; Middle Aged; Osteitis Deformans; Pamidronate; Uveitis; Uveitis, Anteri | 1994 |